Previous studies have demonstrated that phosphorylation at two distinct sites, namely, Ser330 and Thr346, differentially dictates the cellular localization and activity of NDRG1 in various cancer cell types (Park et al., 2018; Sahni et al., 2019). The gene discussed is NDRG1; the disease is cancer.